Growth Metrics

Novartis Ag (NVS) Current Leases (2019 - 2025)

Novartis Ag's Current Leases history spans 7 years, with the latest figure at $263.0 million for Q4 2025.

  • On a quarterly basis, Current Leases rose 11.91% to $263.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $263.0 million, a 11.91% increase, with the full-year FY2025 number at $263.0 million, up 11.91% from a year prior.
  • Current Leases hit $263.0 million in Q4 2025 for Novartis Ag, up from $235.0 million in the prior quarter.
  • Over the last five years, Current Leases for NVS hit a ceiling of $275.0 million in Q4 2021 and a floor of $230.0 million in Q4 2023.
  • Historically, Current Leases has averaged $250.8 million across 5 years, with a median of $251.0 million in 2022.
  • Biggest five-year swings in Current Leases: decreased 8.73% in 2022 and later grew 11.91% in 2025.
  • Tracing NVS's Current Leases over 5 years: stood at $275.0 million in 2021, then decreased by 8.73% to $251.0 million in 2022, then decreased by 8.37% to $230.0 million in 2023, then rose by 2.17% to $235.0 million in 2024, then grew by 11.91% to $263.0 million in 2025.
  • Business Quant data shows Current Leases for NVS at $263.0 million in Q4 2025, $235.0 million in Q4 2024, and $230.0 million in Q4 2023.